×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| SANOFI INDIA LTD | 4150.0 | 695.0 | 4063.0 | 30.18 | 11,751 | 26.6 |
| Vijaya Diagnostic Centre Limit | 1822.68 | 383.89 | 1748.45 | 3.73 | 11367 | 75.4 |
| ALIVUS LIFE SCIENCES LIMITED | 6108.31 | 1215.35 | 6018.46 | 9.88 | 11293 | 22.8 |
Sanofi India Ltd, with Security Code 500674, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 736.5 | 706.1 | 714.6 | 693.9 | 732.4 | 463.5 | 524.0 | 514.9 | 535.9 | 406.3 |
| Expenses | 506.6 | 527.9 | 506.1 | 506.5 | 513.5 | 347.8 | 404.3 | 396.6 | 364.0 | 311.4 |
| Operating Profit | 229.9 | 178.2 | 208.5 | 187.4 | 218.9 | 115.7 | 119.7 | 118.3 | 171.9 | 94.9 |
| OPM % | 31.22% | 25.24% | 29.17% | 27.01% | 29.89% | 24.96% | 22.84% | 22.98% | 32.08% | 23.36% |
| Other Income | 43.6 | 15.7 | 11.8 | 12.0 | -20.2 | -14.2 | 2.3 | 13.9 | 3.3 | 8.7 |
| Interest | 0.3 | 0.7 | 0.3 | 0.4 | 0.3 | 0.4 | 0.4 | 0.4 | 0.3 | 0.4 |
| Depreciation | 9.7 | 9.8 | 9.9 | 10.2 | 10.0 | 9.0 | 9.0 | 9.6 | 9.6 | 9.1 |
| Profit before tax | 245.7 | 183.4 | 210.1 | 188.8 | 215.1 | 111.1 | 112.6 | 114.2 | 165.3 | 94.1 |
| Tax % | -27.7% | -33% | -27.6% | -27.1% | -27.5% | -26% | -27% | 25.3% | -27.7% | 26.1% |
| Net Profit | 190.4 | 122.9 | 152.1 | 137.7 | 136.6 | 103.4 | 82.2 | 91.3 | 119.5 | 69.5 |
| EPS in Rs | 82.67 | 53.37 | 66.08 | 59.79 | 59.31 | 44.9 | 35.69 | 40 | 0 | 30.18 |
| Metrics | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|
| Sales | 706.1 | 714.6 | 693.9 | 732.4 | 463.5 | 524.0 | 514.9 |
| Expenses | 527.9 | 506.3 | 506.5 | 513.5 | 347.8 | 404.3 | 396.6 |
| Operating Profit | 178.2 | 208.3 | 187.4 | 218.9 | 115.7 | 119.7 | 118.3 |
| OPM % | 25.24% | 29.14% | 27.01% | 29.89% | 24.96% | 22.84% | 22.98% |
| Other Income | 15.7 | 11.8 | 12.0 | 6.5 | -14.2 | 2.3 | 13.9 |
| Interest | 0.7 | 0.3 | 0.4 | 0.3 | 0.4 | 0.4 | 0.4 |
| Depreciation | 9.8 | 9.9 | 10.2 | 10.0 | 9.0 | 9.0 | 9.6 |
| Profit before tax | 183.4 | 209.9 | 188.8 | 215.1 | 111.1 | 112.6 | 114.2 |
| Tax % | -33% | -27.6% | -27.1% | 27.5% | 26% | 27% | -25.3% |
| Net Profit | 122.9 | 151.9 | 137.7 | 136.6 | 103.2 | 82.2 | 91.3 |
| EPS in Rs | 53.37 | 65.95 | 59.79 | 59.31 | 44.81 | 35.69 | 39.6 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -8% |
| 3 Years: | -12% |
| TTM: | 3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 0% |
| 3 Years: | -9% |
| TTM: | 12% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 6% |
| 3 Years: | 16% |
| 1 Year: | 14% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 1% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | -25% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 6% |
| 3 Years: | 16% |
| 1 Year: | 14% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|